AzTrials
AzTrials

Horizontal Atrophy of Edentulous Alveolar RidgeNCT06221306

Crestal Bone Loss Around Narrow Diameter Implants Versus Standard Diameter Implants With Bone Augmentation in Horizontally Deficient Posterior Mandibular Sites.

A study testing Dental implant: NDI and Dental implant: SDI in people with Horizontal Atrophy of Edentulous Alveolar Ridge, run by Cairo University at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Dental implant treatment, in many cases, may be impeded by anatomical limitations, such as narrow atrophic ridges. In order to overcome that, additional surgical procedures, such as guided bone regeneration, are often required to augment the deficient hard tissue. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Dental implant: NDI and Dental implant: SDI
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
28 participants
Where
1 siteEgypt
Study dates
1 Feb 2024to Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients having mandibular edentulous posterior site requiring implant placement.
  • Available vertical bone height of ≥ 8 mm in the mandible and ridge width 5-6 mm in width.
  • Tooth extraction ≥3 months before surgical intervention.
  • Patients without systemic diseases interfering with implant therapy.
  • Patients aged ≥ 18 years old.
  • Good oral hygiene.

Who cannot join

  • Patients with systemic conditions known to affect bone metabolism and healing
  • Patients with habits that may jeopardize the implant longevity and affect the results of the study such as parafunctional habits.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Suzy Naiem, MSc contact

+201224785645

suzy.naiem@gmail.com

Hani El Nahass, Professor contact

+201000252603

hani.elnahass@dentistry.cu.edu.eg

Egypt1 site, 1 recruiting
  • Cairo University

    Cairo, Greater Cairo, 12613

    Hani El Nahass, Professor

    Recruiting

Other trials in Egypt

About this study

Official title: Radiographic Evaluation of Crestal Bone Loss Around Narrow Diameter Implants Versus Standard Diameter Implants in Conjunction With Bone Augmentation in Horizontally Deficient Posterior Mandibular Partially Edentulous Sites: A Randomized Clinical Trial

Dental implant treatment, in many cases, may be impeded by anatomical limitations, such as narrow atrophic ridges. In order to overcome that, additional surgical procedures, such as guided bone regeneration, are often required to augment the deficient hard tissue. However, additional surgical procedures often add morbidity to the patient in addition to prolonging the treatment time and raising the treatment cost.

Hence, simpler, less invasive treatment options are preferred by patients. The use of narrow diameter implants (NDI) offers the great advantage of eliminating the need for augmentation procedures.

Read the detailed description

Various methods of additional surgical procedures have been introduced to overcome reduced bone volume situations, relevant to the site, size and nature of the defect such as: maxillary sinus floor lifting and augmentation, vertical and lateral ridge augmentation by means of autogenous or bone substitutes, particulate or blocks. Lateral bone augmentation performed simultaneously with implant placement has been a well-established treatment option for horizontal ridge deficiencies.

Such additional procedures are associated with longer surgical time, greater morbidity and greater risk to complications such as: pain, infection, nerve damage, bleeding, wound dehiscence or even graft or implant failure. In addition to, higher treatment cost and a longer healing time. Furthermore, an additional surgical procedure should be considered with caution in medically compromised patients. Moreover, surgical expertise of the operator is required for performing such procedures.

NDIs showed promising results with reported survival rates 95% - 100%. However, prosthetic complications such as: abutment fracture, loss of crown retention and screw loosening were reported.

The successful outcomes of NDI have supported widening the scope to include premolars and molars, particularly where averting an additional augmentation procedure is favoured.

However, areas of concern remain evident regarding; the impact of loading on a reduced surface for osseointegration, the increased probability of fracture, the probable prosthetic complications and the loading stresses affecting crestal bone resorption. In addition to oral health-related quality of life for the patients. Limited literature is found regarding the use of NDI to restore posterior mandibular edentulous sites.

Several studies have compared NDI to SDI in pristine bone. To our knowledge few RCTs compared NDIs to SDI with simultaneous lateral bone augmentation for the treatment of atrophic posterior mandibular ridges, none assessing both crestal bone resorption in addition to oral health related quality of life (OHRQoL) assessment.

Being tested
Dental implant: NDI, Dental implant: SDI

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dental implant: NDIProcedure or surgery

    Placement of narrow diameter implants (NDI) (3.3) in the dentoalveolar ridge

  • Dental implant: SDIProcedure or surgery

    Placement of standard diameter implants (SDI) (4.1) in the dentoalveolar ridge with simaltenous bone augmentation

Study groups in NCT06221306
Study groupRoleWhat they receive
Narrow diameter implant placement (NDI) (3.3)ExperimentalNot described
Receives: Procedure: Dental implant: NDI
Standard diameter implant (SDI) placement (4.1) with simultaneous bone augmentation.Active comparatorNot described
Receives: Procedure: Dental implant: SDI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Amount of crestal bone changes

    Linear measurements (in mm) for the crestal bone level changes on periapical digital radiographs

    Measured: 1 year

Secondary outcomes (1)
  1. Prosthetic complications

    screw loosening, fracture of restoration

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jan 2024
  2. Study start1 Feb 2024
  3. Primary completionNov 2026 (estimated)
  4. Study completionApr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
28 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06221306
Sponsor's protocol ID
blt
Status last verified
Jan 2026
First submitted
17 Dec 2023
Last updated
23 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Dental implant: NDI and Dental implant: SDI in people with Horizontal Atrophy of Edentulous Alveolar Ridge, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Suzy Naiem, MSc (+201224785645, suzy.naiem@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Amount of crestal bone changes (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in